Previous close | 72.50 |
Open | 73.28 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 72.71 - 72.83 |
52-week range | 57.97 - 81.40 |
Volume | |
Avg. volume | 354,443 |
Market cap | 1.2B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 0.26 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....